Clinical Trial Update: Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating Proxinium plus best supportive care versus best supportive care for advanced head and neck cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Proxinium

Snippet

Sponsor: Sesen Bio, Inc. | Conditions: Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Squamous Cell | Phase 2, Phase 3 | Status: TERMINATED